SFS 2014:1480 Förordning om ändring i förordningen (1992:1554) om kontroll av narkotika

<div><style type="text/css"> <!-- p {margin: 0; padding: 0;} .ft10{font-size:14px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft11{font-size:27px;font-family:IDPOMH+TimesNewRomanPS;color:#000000;} .ft12{font-size:19px;font-family:IDPOMH+TimesNewRomanPS;color:#000000;} .ft13{font-size:8px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft14{font-size:7px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft15{font-size:12px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft16{font-size:19px;line-height:19px;font-family:IDPOMH+TimesNewRomanPS;color:#000000;} .ft17{font-size:14px;line-height:17px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft18{font-size:12px;line-height:14px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft19{font-size:12px;line-height:12px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft110{font-size:12px;line-height:15px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft20{font-size:14px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft21{font-size:15px;font-family:IDPOMH+TimesNewRomanPS;color:#000000;} .ft22{font-size:14px;font-family:IDPOPI+TimesNewRomanPS;color:#000000;} .ft23{font-size:8px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft24{font-size:14px;font-family:IDPPAJ+Symbol;color:#000000;} .ft25{font-size:7px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft26{font-size:12px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft27{font-size:15px;line-height:17px;font-family:IDPOMH+TimesNewRomanPS;color:#000000;} .ft28{font-size:14px;line-height:17px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft30{font-size:14px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft31{font-size:15px;font-family:IDPOMH+TimesNewRomanPS;color:#000000;} .ft32{font-size:14px;font-family:IDPOPI+TimesNewRomanPS;color:#000000;} .ft33{font-size:14px;line-height:17px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft40{font-size:14px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft41{font-size:15px;font-family:IDPOMH+TimesNewRomanPS;color:#000000;} .ft42{font-size:14px;font-family:IDPOPI+TimesNewRomanPS;color:#000000;} .ft43{font-size:14px;line-height:17px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft50{font-size:14px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} .ft51{font-size:15px;font-family:IDPOMH+TimesNewRomanPS;color:#000000;} .ft52{font-size:14px;line-height:17px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft60{font-size:8px;font-family:IDPOMG+TimesNewRomanPS;color:#000000;} --> </style> <div id="page1-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:646px;white-space:nowrap" class="ft10">1</p> <p style="position:absolute;top:80px;left:77px;white-space:nowrap" class="ft11"><b>Svensk f�rfattningssamling</b></p> <p style="position:absolute;top:184px;left:77px;white-space:nowrap" class="ft16"><b>F�rordning<br/>om �ndring i f�rordningen (1992:1554) om kontroll <br/>av narkotika;</b></p> <p style="position:absolute;top:259px;left:77px;white-space:nowrap" class="ft10">utf�rdad den 11 december 2014.</p> <p style="position:absolute;top:294px;left:91px;white-space:nowrap" class="ft10">Regeringen f�reskriver</p> <p style="position:absolute;top:292px;left:227px;white-space:nowrap" class="ft13">1 att bilaga 1 till f�rordningen (1992:1554) om</p> <p style="position:absolute;top:312px;left:77px;white-space:nowrap" class="ft10">kontroll av narkotika</p> <p style="position:absolute;top:310px;left:196px;white-space:nowrap" class="ft13">2 ska ha f�ljande lydelse.</p> <p style="position:absolute;top:348px;left:91px;white-space:nowrap" class="ft10">Denna f�rordning tr�der i kraft den 16 januari 2015.</p> <p style="position:absolute;top:382px;left:77px;white-space:nowrap" class="ft10">P� regeringens v�gnar</p> <p style="position:absolute;top:417px;left:77px;white-space:nowrap" class="ft10">GABRIEL WIKSTR�M</p> <p style="position:absolute;top:434px;left:307px;white-space:nowrap" class="ft17">Lars Hedengran<br/>(Socialdepartementet)</p> <p style="position:absolute;top:885px;left:77px;white-space:nowrap" class="ft19">1 Se Europaparlamentets och r�dets direktiv 98/34/EG av den 22 juni 1998 om ett in-<br/>formationsf�rfarande betr�ffande tekniska standarder och f�reskrifter och betr�ffande<br/>f�reskrifter f�r informationssamh�llets tj�nster.</p> <p style="position:absolute;top:923px;left:77px;white-space:nowrap" class="ft14">2 F�rordningen omtryckt 1993:784.</p> <p style="position:absolute;top:175px;left:536px;white-space:nowrap" class="ft12"><b>SFS 2014:1480</b></p> <p style="position:absolute;top:202px;left:536px;white-space:nowrap" class="ft110">Utkom fr�n trycket<br/>den 19 december 2014</p> </div> <div id="page2-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:46px;white-space:nowrap" class="ft20">2</p> <p style="position:absolute;top:51px;left:46px;white-space:nowrap" class="ft21"><b>SFS 2014:1480</b></p> <p style="position:absolute;top:51px;left:571px;white-space:nowrap" class="ft22"><i>Bilaga 1</i></p> <p style="position:absolute;top:49px;left:619px;white-space:nowrap" class="ft23">3</p> <p style="position:absolute;top:94px;left:181px;white-space:nowrap" class="ft27"><b>F�rteckning �ver substanser som ska anses som narkotika enligt <br/>narkotikastrafflagen</b></p> <p style="position:absolute;top:138px;left:181px;white-space:nowrap" class="ft22"><i>Centralstimulerande medel</i></p> <p style="position:absolute;top:164px;left:196px;white-space:nowrap" class="ft28">etylamfetamin (2-etylamino-1-fenylpropan)<br/>fenetyllin<br/>[1-fenyl-1-piperidyl-(2)-metyl]acetat<br/>1-fenyl-2-butylamin<br/>N-hydroxiamfetamin<br/>propylhexedrin<br/>4-metyltioamfetamin (4-MTA)<br/>modafinil<br/>4-metoxi-N-metylamfetamin (PMMA, 4-MMA)<br/>2,5-dimetoxi-4-etyltiofenetylamin (2C-T-2)<br/>2,5-dimetoxi-4-(n)-propyltiofenetylamin (2C-T-7)<br/>4-jodo-2,5-dimetoxifenetylamin (2C-I)<br/>2,4,5-trimetoxiamfetamin (TMA-2)<br/>4-metylmetkatinon (mefedron)<br/>4-fluoramfetamin<br/>1-(4-metoxifenyl)-2-(metylamino)propan-1-on (metedron)<br/>1-(1,3-bensodioxol-5-yl)-2-pyrrolidin-1-yl-pentan-1-on (MDPV)<br/>1-(1,3-bensodioxol-5-yl)-2-(metylamino)butan-1-on (butylon)<br/>1-bensylpiperazin (N-bensylpiperazin)<br/>2-metylamino-1-(3,4-metylendioxifenyl)propan-1-on (metylon)<br/>1-(naftalen-2-yl)-2-pyrrolidin-1-yl-pentan-1-on (nafyron)<br/>2-etylamin-1-fenyl-propan-1-on (N-etylkatinon)<br/>1-(2-fluorfenyl)-2-(metylamino)propan-1-on<br/>1-(3-fluorfenyl)-2-(metylamino)propan-1-on<br/>1-(4-fluorfenyl)-2-(metylamino)propan-1-on (flefedron)<br/>2-benshydrylpiperidin (desoxipipradol)<br/>metyl(E)-2-[(2S,3S,12bS)-3-etyl-8-metoxi-1,2,3,4,6,7,12,12b-okta-</p> <p style="position:absolute;top:634px;left:181px;white-space:nowrap" class="ft20"> hydroindol[2,3-a]quinolizin-2-yl]-3-metoxiprop-2-enoat (mitragynin)</p> <p style="position:absolute;top:651px;left:196px;white-space:nowrap" class="ft28">(8-metyl-8-azabicyklo[3.2.1]oktan-3-yl)-4-flourbensoat (pFBT)<br/>2-etylamin-1-(4-metylfenyl)-1-propanon (4-MEC)<br/>2-metylamin-1-fenylbutan-1-on (bufedron)<br/>etyl-2-fenyl-2-(piperidin-2-yl)acetat (etylfenidat)<br/>1-(4-metylfenyl)propan-2-amin (4-MA)<br/>1-fenyl-2-(1-pyrrolidinyl)-1-propanon (</p> <p style="position:absolute;top:734px;left:422px;white-space:nowrap" class="ft24">�-PPP)</p> <p style="position:absolute;top:755px;left:196px;white-space:nowrap" class="ft20">1-fenyl-2-(pyrrolidin-1-yl)-pentan-1-on (</p> <p style="position:absolute;top:752px;left:430px;white-space:nowrap" class="ft24">�-PVP)</p> <p style="position:absolute;top:773px;left:196px;white-space:nowrap" class="ft28">1-fenyl-2-(metylamino)-pentan-1-on (pentedron)<br/>(2S)-2,6-diamino-N-[(2S)-1-fenylpropan-2-yl]hexanamid (lisdexamfeta-</p> <p style="position:absolute;top:808px;left:181px;white-space:nowrap" class="ft20">min)</p> <p style="position:absolute;top:825px;left:196px;white-space:nowrap" class="ft28">1-(2-fluorofenyl)-N-metylpropan-2-amin (2-fluorometamfetamin, 2-FMA)<br/>1-(3-fluorofenyl)-N-metylpropan-2-amin (3-fluorometamfetamin, 3-FMA)<br/>1-(4-fluorofenyl)-N-metylpropan-2-amin (4-fluorometamfetamin, 4-FMA)<br/>1-(2-fluorofenyl)propan-2-amin (2-fluoroamfetamin)</p> <p style="position:absolute;top:921px;left:181px;white-space:nowrap" class="ft25">3 Senaste lydelse 2014:1379.</p> </div> <div id="page3-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:649px;white-space:nowrap" class="ft30">3</p> <p style="position:absolute;top:51px;left:536px;white-space:nowrap" class="ft31"><b>SFS 2014:1480</b></p> <p style="position:absolute;top:51px;left:91px;white-space:nowrap" class="ft33">1-(3-fluorofenyl)propan-2-amin (3-fluoroamfetamin)<br/>1-(3-metylfenyl)-2-(metylamino)propan-1-on (3-MMC)<br/>1-(4-etylfenyl)-2-(metylamino)propan-1-on (4-EMC)<br/>6,7-dihydro-5H-cyklopenta[f][1,3]bensodioxol-6-amin (MDAI)<br/>1-(3,4-dimetylfenyl)-2-(metylamino)propan-1-on (3,4-DMMC)<br/>5-(N-etyl-2-aminopropyl)bensofuran (5-EAPB)<br/>N-metyl-1-(tiofen-2-yl)propan-2-amin (metiopropamin) <br/>5-(2-aminopropyl)indol (5-IT)<br/>1-(1,3-bensodioxol-5-yl)-2-(metylamino)pentan-1-on (pentylon) <br/>1-fenyl -2-(pyrrolidin-1-yl)butan-1-on (alfa-PBP)<br/>1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4F-alfa-PVP)<br/>1-(4-metylfenyl)-2-(pyrrolidin-1-yl)propan-1-on ( p-MePPP)<br/>metyl-2-(3,4-diklorofenyl)-2-(piperidin-2-yl)acetat (3,4-diklorometyl-feni-</p> <p style="position:absolute;top:277px;left:77px;white-space:nowrap" class="ft30">dat)</p> <p style="position:absolute;top:294px;left:91px;white-space:nowrap" class="ft30">2-amino-4-metyl-5-(4-metylfenyl)-2-oxazolin (4,4-dimetylaminorex)</p> <p style="position:absolute;top:338px;left:77px;white-space:nowrap" class="ft32"><i>Hallucinogener</i></p> <p style="position:absolute;top:364px;left:91px;white-space:nowrap" class="ft33">2-amino-1-(4-brom-2,5-dimetoxifenyl)propan (brom-STP)<br/>hydroxi-3-pentyl-6,6,9-trimetyl-6a,7,10,10a-tetrahydro-6H-dibenso[b,d]</p> <p style="position:absolute;top:399px;left:77px;white-space:nowrap" class="ft30">pyranol-(1) (hydroxitetrahydrocannabinoler)</p> <p style="position:absolute;top:416px;left:91px;white-space:nowrap" class="ft33">ibogain<br/>levonantradol<br/>nabilon <br/>4-jod-2,5-dimetoxiamfetamin (DOI)<br/>4-klor-2,5-dimetoxiamfetamin (DOC)<br/>brombensodifuranylisopropylamin (Bromo-Dragonfly)<br/>dextrometorfan med undantag f�r beredningar f�r medicinskt eller veten-</p> <p style="position:absolute;top:538px;left:77px;white-space:nowrap" class="ft30">skapligt bruk i form av l�sningar som inte inneh�ller mer �n 3 mg/ml</p> <p style="position:absolute;top:555px;left:91px;white-space:nowrap" class="ft30">5-(1,1-Dimethylhexyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol</p> <p style="position:absolute;top:573px;left:77px;white-space:nowrap" class="ft30">(CP47,497-C6)</p> <p style="position:absolute;top:590px;left:91px;white-space:nowrap" class="ft30">5-(1,1-Dimethylheptyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol</p> <p style="position:absolute;top:607px;left:77px;white-space:nowrap" class="ft30">(CP47,497-C7)</p> <p style="position:absolute;top:625px;left:91px;white-space:nowrap" class="ft30">5-(1,1-Dimethyloctyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol</p> <p style="position:absolute;top:642px;left:77px;white-space:nowrap" class="ft30">(CP47,497-C8)</p> <p style="position:absolute;top:660px;left:91px;white-space:nowrap" class="ft30">5-(1,1-Dimethylnonyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol</p> <p style="position:absolute;top:677px;left:77px;white-space:nowrap" class="ft30">(CP47,497-C9)</p> <p style="position:absolute;top:694px;left:91px;white-space:nowrap" class="ft33">Naphthalene-1-yl-(1-pentylindol-3-yl)methanon (JWH-018)<br/>Naphthalene-1-yl-(1-butylindol-3-yl)methanon (JWH-073)<br/>4-metoxinaftalen-1-yl-(1-pentylindol-3-yl)metanon (JWH-081)<br/>4-metylnaftalen-1-yl-(1-pentylindol-3-yl)metanon (JWH-122)<br/>[1-[2-(4-morfolinyl)etyl]-1H-indol-3-yl]-1-naftalenylmetanon (JWH-200)<br/>2-(2-klorophenyl)-1-(1-pentylindol-3-yl)etanon (JWH-203)<br/>4-etylnaftalen-1-yl-(1-pentylindol-3-yl)metanon (JWH-210)<br/>2-(2-metoxifenyl)-1-(1-pentyl-1H-indol-3-yl)etanon (JWH-250)<br/>(4-klornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon (JWH-398)<br/>(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)</p> <p style="position:absolute;top:868px;left:77px;white-space:nowrap" class="ft30">6a,7,10,10a,tetrahydrobenzo[c]chromen-1-ol) (HU-210)</p> <p style="position:absolute;top:886px;left:91px;white-space:nowrap" class="ft33">(2-metoxifenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4 orto isomer)<br/>2-(etylamino)-2-(3-metoxifenyl)cyklohexanon (metoxetamin)<br/>1-[(5-fluoropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (AM-2201)</p> </div> <div id="page4-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:46px;white-space:nowrap" class="ft40">4</p> <p style="position:absolute;top:51px;left:46px;white-space:nowrap" class="ft41"><b>SFS 2014:1480</b></p> <p style="position:absolute;top:51px;left:196px;white-space:nowrap" class="ft43">1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-jodofenyl)metanon (AM-694)<br/>N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin </p> <p style="position:absolute;top:85px;left:181px;white-space:nowrap" class="ft40">(5-MeO-DALT)</p> <p style="position:absolute;top:103px;left:196px;white-space:nowrap" class="ft43">3-[2-[etyl(metyl)amino]etyl]-1H-indol-4-ol (4-HO-MET)<br/>(1-(5-fluoropentyl)-1H-indol-3-yl)(4-metyl-1-naftalen-1-yl)metanon</p> <p style="position:absolute;top:138px;left:181px;white-space:nowrap" class="ft40">(MAM-2201)</p> <p style="position:absolute;top:155px;left:196px;white-space:nowrap" class="ft40">(1-((1-metylpiperidin-2-yl)metyl)-1H-indol-3-yl)(naftalen-1-yl)-metanon</p> <p style="position:absolute;top:172px;left:181px;white-space:nowrap" class="ft40">(AM-1220)</p> <p style="position:absolute;top:190px;left:196px;white-space:nowrap" class="ft40">(2-jodofenyl)(1-((1-metylpiperidin-2-yl)metyl)-1H-indol-3-yl)metanon</p> <p style="position:absolute;top:207px;left:181px;white-space:nowrap" class="ft40">(AM-2233)</p> <p style="position:absolute;top:225px;left:196px;white-space:nowrap" class="ft43">2-(4-jodo-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin (25I-NBOMe)<br/>2-(4-kloro-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin </p> <p style="position:absolute;top:259px;left:181px;white-space:nowrap" class="ft40">(25C-NBOMe)</p> <p style="position:absolute;top:277px;left:196px;white-space:nowrap" class="ft40">2-(4-bromo-2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin </p> <p style="position:absolute;top:294px;left:181px;white-space:nowrap" class="ft40">(25B-NBOMe)</p> <p style="position:absolute;top:312px;left:196px;white-space:nowrap" class="ft40">2-(2,5-dimetoxi-4-metylfenyl)-N-(2-metoxibensyl)etanamin </p> <p style="position:absolute;top:329px;left:181px;white-space:nowrap" class="ft40">(25D-NBOMe)</p> <p style="position:absolute;top:346px;left:196px;white-space:nowrap" class="ft43">2-(2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin (25H-NBOMe)<br/>(1-(5-fluoropentyl)-1H-indol-3-yl)(4-etyl-naftalen-1-yl)metanon </p> <p style="position:absolute;top:381px;left:181px;white-space:nowrap" class="ft40">(EAM-2201)</p> <p style="position:absolute;top:399px;left:196px;white-space:nowrap" class="ft40">2-(4-jodo-2,5-dimetoxifenyl)-N-[(2,3-metylendioxifenyl)metyl]etanamin</p> <p style="position:absolute;top:416px;left:181px;white-space:nowrap" class="ft40">(25I-NBMD)</p> <p style="position:absolute;top:433px;left:196px;white-space:nowrap" class="ft40">2-(2,5-dimetoxi-3,4-dimetylfenyl)-N-(2-metoxibensyl)etanamin (25G-</p> <p style="position:absolute;top:451px;left:181px;white-space:nowrap" class="ft40">NBOMe)</p> <p style="position:absolute;top:468px;left:196px;white-space:nowrap" class="ft40">2-(2,5-dimetoxi-4-nitrofenyl)-N-(2-metoxibensyl)etanamin (25N-</p> <p style="position:absolute;top:486px;left:181px;white-space:nowrap" class="ft40">NBOMe)</p> <p style="position:absolute;top:529px;left:181px;white-space:nowrap" class="ft42"><i>Sm�rtstillande medel</i></p> <p style="position:absolute;top:555px;left:196px;white-space:nowrap" class="ft43">karfentanil<br/>karisoprodol<br/>remifentanil<br/>gamma-hydroxi-butyrat (GHB)<br/>ketamin<br/>tapentadol<br/>tramadol <br/>O-desmetyltramadol (ODT)<br/>3,4-dikloro-N-[[1-(dimetylamino)cyklohexyl]metyl]bensamid (AH-7921)<br/>1-cyklohexyl-4-(1,2-difenyletyl)piperazin (MT-45)<br/>4-kloro-N-(1-(2-fenyletyl)-piperidin-2-yliden)bensensulfonamid (W-15)<br/>1-[1-(3-metoxifenyl)cyklohexyl]piperidin (3-MeO-PCP)<br/>1-[1-(4-metoxifenyl)cyklohexyl]piperidin (4-MeO-PCP)</p> <p style="position:absolute;top:808px;left:181px;white-space:nowrap" class="ft42"><i>S�mnmedel och lugnande medel</i></p> <p style="position:absolute;top:834px;left:196px;white-space:nowrap" class="ft43">allobarbital<br/>aprobarbital<br/>brallobarbital<br/>brotizolam<br/>butalbarbital<br/>pyrityldion (3,3-dietyl-2,4-dioxotetrahydropyridin)</p> </div> <div id="page5-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:649px;white-space:nowrap" class="ft50">5</p> <p style="position:absolute;top:51px;left:536px;white-space:nowrap" class="ft51"><b>SFS 2014:1480</b></p> <p style="position:absolute;top:51px;left:91px;white-space:nowrap" class="ft52">heptabarbital<br/>hexapropymat<br/>hexobarbital<br/>klometiazol<br/>kloralhydrat<br/>kloralodol<br/>metohexital<br/>metylpentynol<br/>midazolam<br/>tybamat<br/>vinbarbital<br/>zolpidem<br/>zopiclone<br/>fenazepam<br/>etizolam (4-(o-klorofenyl)-2-etyl-9-metyl-6H-tieno[3,2-f]-s-triazolo[4,3-</p> <p style="position:absolute;top:312px;left:77px;white-space:nowrap" class="ft50">a][1,4]diazepin)</p> <p style="position:absolute;top:329px;left:91px;white-space:nowrap" class="ft50">8-bromo-1-metyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]bensodia-</p> <p style="position:absolute;top:346px;left:77px;white-space:nowrap" class="ft50">zepin (pyrazolam)</p> <p style="position:absolute;top:364px;left:91px;white-space:nowrap" class="ft50">7-bromo-5-(2-fluorofenyl)-1,3-dihydro-2H-1,4-bensodiazepin-2-on </p> <p style="position:absolute;top:381px;left:77px;white-space:nowrap" class="ft50">(flubromazepam)</p> <p style="position:absolute;top:399px;left:91px;white-space:nowrap" class="ft50">7-kloro-5-(2-klorofenyl)-1,3-dihydro-1-metyl-2H-1,4-bensodiazepin-2-on</p> <p style="position:absolute;top:416px;left:77px;white-space:nowrap" class="ft50">(diklazepam)</p> <p style="position:absolute;top:451px;left:91px;white-space:nowrap" class="ft50">Som narkotika enligt narkotikastrafflagen ska �ven anses de ovanjordiska</p> <p style="position:absolute;top:468px;left:77px;white-space:nowrap" class="ft52">delarna av v�xten kat (Catha edulis) samt svamparna Psilocybe semilanceata<br/>(toppsl�tskivling) och Psilocybe cubensis. Detsamma ska g�lla andra svampar<br/>som inneh�ller �mnena psilocybin eller psilocin, om svamparna �r fram-<br/>odlade eller om de har torkats eller p� annat s�tt beretts.</p> <p style="position:absolute;top:541px;left:94px;white-space:nowrap" class="ft50">Vidare ska vid till�mpning av lagen med cannabis f�rst�s de ovanjordiska</p> <p style="position:absolute;top:558px;left:77px;white-space:nowrap" class="ft52">delarna av varje v�xt av sl�ktet Cannabis (med undantag av fr�n), fr�n vilka<br/>hartset icke blivit extraherat och oavsett under vilka ben�mningar de<br/>f�rekommer. Med cannabis ska dock inte f�rst�s hampa som</p> <p style="position:absolute;top:609px;left:94px;white-space:nowrap" class="ft50">1. �r av en sort som kan ber�ttiga till st�d enligt r�dets f�rordning (EG) nr</p> <p style="position:absolute;top:626px;left:77px;white-space:nowrap" class="ft52">73/2009 av den 19 januari 2009 om uppr�ttande av gemensamma<br/>best�mmelser f�r system f�r direktst�d f�r jordbrukare inom den<br/>gemensamma jordbrukspolitiken och om uppr�ttande av vissa st�dsystem f�r<br/>jordbrukare, om �ndring av f�rordningarna (EG) nr 1290/2005, (EG) nr 247/<br/>2006 och (EG) nr 378/2007 samt om upph�vande av f�rordning (EG) nr<br/>1782/2003, Europaparlamentets och r�dets f�rordning (EU) nr 1307/2013 av<br/>den 17 december 2013 om regler f�r direktst�d f�r jordbrukare inom de<br/>st�dordningar som ing�r i den gemensamma jordbrukspolitiken och om<br/>upph�vande av r�dets f�rordning (EG) nr 637/2008 och r�dets f�rordning<br/>(EG) 73/2009, och Europaparlamentets och r�dets f�rordning (EU) nr 1308/<br/>2013 av den 17 </p> <p style="position:absolute;top:797px;left:199px;white-space:nowrap" class="ft50">december 2013 om uppr�ttande av en samlad</p> <p style="position:absolute;top:814px;left:77px;white-space:nowrap" class="ft52">marknadsordning f�r jordbruksprodukter och om upph�vande av r�dets<br/>f�rordningar (EEG) nr 922/72, (EEG) nr 234/79, (EG) nr 1037/2001 och (EG)<br/>nr 1234/2007,</p> <p style="position:absolute;top:865px;left:94px;white-space:nowrap" class="ft50">2. odlas efter det att ans�kan om direktst�d f�r s�dan odling enligt r�dets</p> <p style="position:absolute;top:882px;left:77px;white-space:nowrap" class="ft52">f�rordning (EG) nr 1307/2013 eller r�dets f�rordning (EG) nr 73/2009 getts<br/>in till beh�rig myndighet. </p> </div> <div id="page6-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:946px;left:529px;white-space:nowrap" class="ft60">Norstedts Juridik AB/Fritzes</p> <p style="position:absolute;top:956px;left:534px;white-space:nowrap" class="ft60">Elanders Sverige AB, 2014</p> </div> </div> ;